GT Biopharma Names Charles J. Casamento to the Board of Directors

Stock Information for GT Biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About GT Biopharma Inc.

GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit
GT Biopharma Announces Exercise of Warrants
GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies
GT Biopharma Reports Third Quarter 2024 Financial Results
GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024
GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.